To directly determine whether the protective function of CD19+ B cells primed in the 67NR tumor context depends on their capacity to produce OPG, we employed a stringent experimental model using BALB/c SCID mice that are genetically deficient in both T and B lymphocytes. This evidence concerns the gene CD19 and neoplasm.